Greetings to you.

This is regarding the report filed by you today “ US to withdraw charges against Ranbaxy”

I would like to clarify to you, that there are no charges filed against Ranbaxy in the US , there was only a motion filed by Department of Justice, which will be withdraw upon submission of all documents by Ranbaxy.

Which Mr. Malvinder Singh, CEO & MD, Ranbaxy had also commented.

Given below is his quote in which he talks about the Motion being withdrawn, which has been incorrectly put as charges in the headdline of your story.

“We have received a written communication and we have also been given to understand during discussions that once we complete filing all the information sought by the USFDA, the motion against us will be withdrawn,” Malvinder Mohan Singh, Ranbaxy”

You had put the story based on the IANS report filed today, which had the incorrect headline, since then they have corrected it and put the updated version on their website.

Kindly request you to please correct the story filed on your web site immediately.